The Duke Clinical Vaccine Unit is a consortium of investigators committed to conducting clinical investigations related to the control and prevention of infectious disease with an overarching goal of furthering our understanding of vaccine immune responses and correlates of protection from infection.
October 27, 2015: Duke VTEU Names Valley Fever External Advisory Panel
February 27, 2014: Dr. Walter presented a review of vaccine safety concernscomparing live attenuated influenza vaccine to inactivated influenza vaccine in children at the February 26-27, 2014 meeting of the advisory committee on immunization practices (ACIP) at the CDC.
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. Libster R, McNeal M, Walter EB, Shane AL, Winkour P, Cress G, Berry AA, Kotloff KL, Sarpong K, Turley CB, Harrison CJ, Pahud BA, Marbin J, Dunn J, El-Khorazaty J, Barrett J, and Edwards KM. Pediactrics 2016 February: 137(2):e20152603.
Maternal benefits of immunization during pregnancy. Swamy GK and Beigi RH. Vaccine. 2015 September 16. pii: S0264-410X(15)01162-7. doi: 10.1016/j.vaccine.2015.08.035.
The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Moro PL, McNeil MM, Sukumaran L, and Broder KR. Human Vaccines & Immunotherapeutics. 2015 November 11:11, doi: 10.1080/21645515.2015.1072664.
Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals. Russell K, Dunne EF, Kemper AR, Dolor RJ, Unger ER, Panicker G, Markowitz LE, Walter EB. Vaccine. 2015 Mar 3. pii: S0264-410X(15)00247-9. doi: 10.1016/j.vaccine.2015.02.058